AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Albendazole in South Africa
8 products registered with SAHPRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CIPLA-MEDPRO ALBENDAZOLE | 34/12/0072 | Cipla Medpro (Pty) Ltd | suspended | 16 Jul 2025 |
| ZENTEL SUSPENSION 20 mg/ml | Q/12/75 | GlaxoSmithKline South Africa (Pty) Limited | suspended | 21 Nov 2023 |
| NUBEND-400 | A38/12/0425 | PHARMASCRIPT PHARMACEUTICALS LTD | suspended | 30 Jul 2022 |
| PARANTHIL SUSPENSION | 29/12/0553 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| PARANTHIL TABLETS | 29/12/0552 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ZENTEL 400 | 30/12/0354 | GlaxoSmithKline South Africa (Pty) Limited | active | 1 Jan 1900 |
| BENDEX-400 | 31/12/0472 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| WORMADOLE | A38/12/0426 | Dezzo Trading 392 (Pty) Ltd | active | 1 Jan 1900 |
Albendazole — SAHPRA Registration Details
SAHPRA (South Africa) has 8 registered products containing Albendazole, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Albendazole registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.